Press Releases Medexus Pharmaceuticals Inc.

Equities

MDP

CA58410Q2036

Delayed Toronto S.E. Other stock markets 15:30:12 21/05/2024 BST			5-day change	1st Jan Change
1.62 ^CAD	+1.25%		+1.25%	-34.41%

03-26	Medexus Pharmaceuticals Announces US Food and Drug Administration Approves It's Supplemental Biologics License Application for IXINITY(R)	CI
02-09	Medexus Pharmaceuticals Maintained at Speculative Buy at Stifel GMP After Fiscal Q3 Miss; Price Target Cut to C$2.85	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Federal Court Finds Patent For Concentrated Methotrexate Solutions Obvious	05-07	AQ
Medexus Concludes Metoject Litigation, Patent No Longer in Effect in Canada	05-01	NE
Medexus to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference	04-02	NE
FDA Approves Medexus's Supplemental Biologics License Application for IXINITY to Treat Hemophilia B in Pediatric Patients	03-27	AQ
FDA Approves Medexus's Supplemental Biologics License Application for IXINITY(R) to Treat Hemophilia B in Pediatric Patients	03-26	NE
Medexus Announces Fiscal Q3 2024 Results	02-07	NE
Medexus Schedules Third Fiscal Quarter 2024 Conference Call	01-30	NE
Medexus Pharmaceuticals - Health Canada Accepts for Review Medexus's New Drug Submission for Topical Terbinafine	01-09	AQ
Health Canada Accepts for Review Medexus's New Drug Submission for Topical Terbinafine	01-08	NE
Medexus Announces Strong Fiscal Q2 2024 Results, Including Quarterly Revenue of US$30.3 Million	11-08	NE
Medexus Schedules Second Fiscal Quarter 2024 Conference Call	11-01	NE
Medexus Announces Full Exercise and Closing of Over-Allotment Option in Bought-Deal Public Offering	17/10/23	NE
Canadian Investment Regulatory Organization Trading Halt - MDP.DB	16/10/23	AQ
Medexus Fully Repays Convertible Debentures In Cash At Maturity	16/10/23	NE
Medexus Announces Closing of C$10 Million Bought-Deal Public Offering	09/10/23	AQ
Medexus Announces Closing of C$10 Million Bought-Deal Public Offering	06/10/23	NE
Medexus and medac Agree to Amend US Treosulfan Agreement	29/09/23	NE
Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors	21/09/23	NE
Medexus Strengthens Balance Sheet with US$18 Million Commitment under Accordion Facility	06/09/23	AQ
Medexus Pharmaceuticals Announces C$10 Million Bought-Deal Public Offering of Units	05/09/23	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Medexus Pharmaceuticals Inc.

Equities

MDP

CA58410Q2036

Press Releases

Filters